# Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients

> **NCT02183688** · PHASE3 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 1889 (actual)

## Conditions studied

- Migraine Disorders

## Interventions

- **DRUG:** Low dose ASA
- **DRUG:** High dose ASA
- **DRUG:** Low dose paracetamol
- **DRUG:** High dose paracetamol
- **DRUG:** Caffeine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02183688
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 2003-01
- **Final completion:** —
- **Target enrollment:** 1889 (ACTUAL)
- **Last updated:** 2014-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02183688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02183688, "Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02183688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*